TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse

Hepatology

Volumn 47, Issue 4, 2008, Pages 1317-1330

  Kahraman, Alisan ^a,b   Barreyro, Fernando J ^a   Bronk, Steven F ^a   Werneburg, Nathan W ^a   Mott, Justin L ^a   Akazawa, Yuko ^a   Masuoka, Howard C ^a   Howe, Charles L ^c   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; CASPASE 7; MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL FUNCTION; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; INNATE IMMUNITY; LIVER CELL; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; SURVIVAL; UPREGULATION;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CATHEPSIN B; CHOLESTASIS, EXTRAHEPATIC; HEPATIC DUCT, COMMON; HEPATOCYTES; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LIGATION; LIVER; LIVER CIRRHOSIS; LYSOSOMES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 42249091320     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22136     Document Type: Article

References (53)

1. Emerick KM, Whitington PF. Neonatal liver disease. Pediatr Ann 2006;35:280-286.
2. LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, et al. Primary sclerosing cholangitis: summary of a workshop. HEPATOLOGY 2006;44:746-764.
3. Lazaridis KN, Talwalkar JA. Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. J Clin Gastroenterol 2007;41:494-500.
4. Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 2003;83:655-663.
5. Gujral JS, Farhood A, Bajt ML, Jaeschke H. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. HEPATOLOGY 2003;38:355-363.
6. Racanelli V, Rehermann B. The liver as an immunological organ. HEPATOLOGY 2006;43:S54-S62.
7. Rust C, Gores GJ. Apoptosis and liver disease. Am J Med 2000;108:567-574.
8. Yoon JH, Gores GJ. Death receptor-mediated apoptosis and the liver. J Hepatol 2002;37:400-410.
9. Miyoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999;117:669-677.
10. Gujtal JS, Liu J, Farhood A, Jaeschke H. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice aftet bile duct ligation. HEPATOLOGY 2004;40:998-1007.
11. Higuchi H, Bronk SF, Takikawa Y, Werneburg N, Takimoto R, El-Deiry W, et al. The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis. J Biol Chem 2001;276:38610-38618.
12. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997;277:818-821.
13. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999;104:155-162.
14. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, et al. Tumoricidal acrivity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999;5:157-163.
15. Sadarangani A, Kato S, Espinoza N, Lange S, Llados C, Espinosa M, et al. TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract. Apoptosis 2007;12:73-85.
16. Malhi H, Barreyro F, Isomoto H, Bronk SF, Gores GJ. Free fatty acids sensitize hepatocytes to trial medicated cytotoxicity. Gut 2007;56:1124-1131.
17. Corazza N, Jakob S, Schaer C, Frese S, Keogh A, Stroka D, et al. TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J Clin Invest 2006;116:2493-2499.
18. Jones BE, Czaja MJ III. Intracellular signaling in response to toxic liver injury. Am J Physiol 1998;275:G874-G878.
19. Herr I, Schemmer P, Buchler MW. On the TRAIL to therapeutic intervention in liver disease. HEPATOLOGY 2007;46:266-274.
20. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. HEPATOLOGY 2003;38:1188-1198.
21. Jeong WI, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. HEPATOLOGY 2006;44:1441-1451.
22. Lanier LL. NK cell recognition. Annu Rev Immunol 2005;23:225-274.
23. Radaev S, Sun PD. Structure and function of natural killer cell surface receptors. Annu Rev Biophys Biomol Struct 2003;32:93-114.
24. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis facror superfamily. Nat Rev Cancer 2002;2:420-430.
25. Kelley RF, Totpal K, Lindstrom SH, Mathieu M, Billeci K, Deforge L, et al. Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling. J Biol Chem 2005;280:2205-2212.
26. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002;123:1323-1330.
27. Liu ZX, Govindarajan S, Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004;127:1760-1774.
28. Natori S, Selzner M, Valentino KL, Frirz LC, Srinivasan A, Clavien PA, et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1999;68:89-96.
29. Baskin-Bey ES, Canbay A, Bronk SF, Werneburg N, Guicciardi ME, Nyberg SL, et al. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2005;288:G396-G402.
30. Klaunig JE, Goldblatt PJ, Hinton DE, Lipsky MM, Chacko J, Trump BF. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro 1981;17:913-925.
31. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
32. Kurosawa H, Que FG, Roberts LR, Fesmier PJ, Gores GJ. Hepatocytes in the bile duct-ligated rat express Bcl-2. Am J Physiol 1997;272:G1587-G1593.
33. Arteel GE, Raleigh JA, Bradford BU, Thurman RG. Acute alcohol produces hypoxia directly in rat liver tissue in vivo: role of Kupffer cells. Am J Physiol 1996;271:G494-G500.
34. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326(pt 1):1-16.
35. Guicciardi ME, Bronk SF, Werneburg NW, Gores GJ. cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis. Am J Physiol Gastrointest Liver Physiol 2007;292:G1337-G1346.
36. Reeves HL, Friedman SL. Activation of hepatic stellate cells - a key issue in liver fibrosis. Front Biosci 2002;7:D808-D826.
37. van Dommelen SL, Sumaria N, Schreiber RD, Scalzo AA, Smyth MJ, Degli-Esposti MA. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 2006;25:835-848.
38. Barrie MB, Stout HW, Abougergi MS, Miller BC, Thiele DL. Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6. J Immunol 2004;172:6453-6459.
39. John B, Crispe IN. TLR-4 regulates CD8+ T cell trapping in the liver. J Immunol 2005;175:1643-1650.
40. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444:860-867.
41. Guebre-Xabier M, Yang S, Lin HZ, Schwenk R, Krzych U, Diehl AM. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. HEPATOLOGY 2000;31:633-640.
42. Li Z, Soloski MJ, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. HEPATOLOGY 2005;42:880-885.
43. Volkmann X, Fischer U, Bahr MJ, Ott M, Lehner F, Macfarlane M, et al. Increased hepatotoxicity of tumor necrosis factor-relared apoptosis-inducing ligand in diseased human liver. HEPATOLOGY 2007;46:1498-1508.
44. Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T, et al. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 2001;7:954-960.
45. Koschny R, Walczak H, Ganten TM. The promise of TRAIL-potential and risks of a novel anticancer therapy. J Mol Med 2007.
46. Afford SC, Adams DH. Following the TRAIL from hepatitis C virus and alcohol to fatty liver. Gut 2005;54:1518-1520.
47. Higuchi H, Bronk SF, Taniai M, Canbay A, Gores GJ. Cholestasis increases tumor necrosis factor-related apoprosis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity. J Pharmacol Exp Ther 2002;303:461-467.
48. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2002;2:850-861.
49. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apopto-sis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000;106:1127-1137.
50. Wattiaux R, Wattiaux-de Coninck S, Thirion J, Gasingirwa MC, Jadot M. Lysosomes and Fas-mediated liver cell dearh. Biochem J 2007;403:89-95.
51. Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ. Activated stellate cells express the TRAIL receptor-2/death teceptor-5 and undergo TRAIL-mediated apoptosis. HEPATOLOGY 2003;37:87-95.
52. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Narural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006;130:435-452.
53. Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. HEPATOLOGY 2004;39:273-278.